Skip to main content

Bacteriophage Therapy Market Increase In Transactional And Analytical Needs Across Several Industries 2028

 


Market Size and Analysis

Worldwide, the prevalence of antibiotic resistance is rising, increasing the necessity for efficient substitutes. The CDC estimates that 33 000 persons in Europe are afflicted with antibiotic-resistant bacterial illnesses each year. There will likely be a significant increase in bacterial phage demand as antibiotic resistance is projected to spread globally. Bacteriophage therapy is also known as phage therapy. Viral agents are used to treat bacterial illnesses. The bacterial viruses known as bacteriophages. Phages are viruses that kill bacteria but are safe for plants, animals, and people. The natural enemies of bacteria are assumed to be bacteriophages. Sewage, water, soil, and other places where bacteria are present are home to bacteriophages.

The global bacteriophage therapy market is estimated to be valued at US$ 1,148.6 million in 2020 and is expected to exhibit a CAGR of 3.7% over the forecast period (2020-2030).

Important Factors Driving the Global Bacteriophages Therapy Market

  • Food deterioration contributes to a rise in the occurrence of foodborne illnesses. Viral and bacterial pathogens can be found in spoiled food. According to the WHO, over 600 million individuals (almost 1 in 10 people worldwide) will become unwell in 2019 after eating contaminated food, and 420,000 will die as a result. This will result in the loss of 33 million years of healthy life (DALYs). Additionally, 125,000 deaths annually from foodborne diseases are caused by children under the age of five. This element is accelerating the market for bacteriophages therapy.
  • Bacteriophages attack microorganisms with extreme specificity. Its application is focused on a specific bacterial species, which considerably reduces any unintended effects on the microbiome or humans.

Labels:

Comments

Post a Comment

Popular posts from this blog

The Global Pressure Bandages Market Is Witnessing High Growth Owing To the Increasing Incidence of Surgical Processes in the World

  Market Overview: During a medical emergency, a pressure bandage is used to apply pressure to an area of the body to control bleeding and swelling. There are a variety of types of pressure bandages that can be used for different purposes. The bandage is made up of several parts, including an air bladder, a pad, a closure bar, and an applicator. A pressure bandage can be applied to wounds at any location on the body. This type of dressing is useful in treating various conditions, including gunshot wounds. It can also be used for a temporary holding of a hernia. The bandage is usually vacuum-sealed, so it's easier to carry. Competitive Landscape: Major players operating in the global pressure bandages market include ConvaTec Group PLC., Cardinal Health, 3M, B. Braun Melsungen AG, Lohmann & Rauscher GmbH & Co. KG, Mölnlycke Health Care AB, Smith & Nephew plc., Paul Hartmann AG, and Essity (BSN medical GmbH). Key Market Drivers: Increasing developments by key pla...
Post a Comment
Read more

Increasing Incidences of Infectious Diseases to Augment the Antibacterial Drugs Market Growth

  Antibacterial drugs are widely used to treat and prevent infectious diseases and are categorized into seven major classes, such as β-Lactams, phenicols, macrolides, quinolones, sulfonamides, tetracyclines, and aminoglycosides, based on their molecular structure. Antibacterial drugs destroy or slow down the growth of bacteria. These medications are also used to treat urinary infections caused by S. aureus, E. coli, Streptococcus pyogenes, and other bacterial infections. They include a range of powerful drugs used to treat diseases caused by bacteria. Antibiotics cannot treat viral infections, such as cold, flu, and most coughs. Antibacterial drugs play a major role in advanced healthcare, as they are widely used to treat infectious diseases, such as tuberculosis, malaria, typhoid, leprosy, hepatitis B, HIV/AIDS, and others. Thus, there is an increasing demand for antibacterial drugs worldwide.  
Post a Comment
Read more

Fc Protein and Glycoengineered Antibodies Market Is Booming Worldwide 2023-2028

  Global Fc Protein and Glycoengineered Antibodies Market Drivers Key players in the market are focusing on research and development activities and receiving approvals from regulatory bodies, which are expected to boost the global Fc protein and glycoengineered antibodies market growth over the forecast period. For instance, in 2016, Genentech Inc. received approval from the U.S. Food and drug Administration (U.S. FDA) for Tecentriq (Atezolizumab). It is being used for the treatment of urothelial carcinoma. In March 2019, Tecentriq received its second approval from the U.S. FDA for the treatment of small lung cancer. Furthermore, in November 2017, TG Therapeutics, Inc. began its clinical trial of Ublituximab for the treatment of multiple sclerosis. It is currently in third phase of its clinical trial. Factors such as increasing product approvals and robust pipeline are expected to drive the global fc protein and glycoengineered antibodies market growth.  Increasing preva...
Post a Comment
Read more